AXIN2 and intrahepatic cholangiocarcinoma: To examine whether targeting KRT19+AXIN2+ cells in ICC impaired ICC progression, we generated Krt19-DreER Axin2-CreER R26-Ai66-DTR (DTR hereafter) mice (Figure 3A) (14).